KIF9-AS1 enhances cancer stemness and sorafenib resistance in HCC by promoting Ubiquitin-specific peptidase 1 (USP1)-mediated deubiquitination of short stature homeobox (SHOX2) [113]. The gene discussed is USP1; the disease is hepatocellular carcinoma.